Powder formulation comprising 20-75 wt % of di(4-tert-butylcyclohexyl) peroxydicarbonate and 25-80 wt % of ethylene glycol dibenzoate.

Powder formulation comprising 20-75 wt % of di(4-tert-butylcyclohexyl) peroxydicarbonate and 25-80 wt % of ethylene glycol dibenzoate.

An online continuous flow production process for directly preparing organic peroxides by using hydrogen peroxide as a raw material. This production process uses hydrogen peroxide, catalyst, and an oxidation substrate as a raw material. Substrate will be turned to designated peroxides sequentially through oxidation and workup. This process is performed in a plug-and-produce integrated continuous flow reactor, and the raw materials are continuously fed to the reactor. So, specified peroxide can be continuously obtained at the outlet of the plug-and-produce integrated continuous flow reactor.

An online continuous flow production process for directly preparing organic peroxides by using hydrogen peroxide as a raw material. This production process uses hydrogen peroxide, catalyst, and an oxidation substrate as a raw material. Substrate will be turned to designated peroxides sequentially through oxidation and workup. This process is performed in a plug-and-produce integrated continuous flow reactor, and the raw materials are continuously fed to the reactor. So, specified peroxide can be continuously obtained at the outlet of the plug-and-produce integrated continuous flow reactor.

The invention relates to the reduction of the burning rate of di-(4-tert-butylcyclohexyl)-peroxydicarbonate (BCHPC) by adding desensitizers as well as to the use of BCHPC preparations having a reduced burning rate as an initiator in chemical reactions.

The invention relates to the reduction of the burning rate of di-(4-tert-butylcyclohexyl)-peroxydicarbonate (BCHPC) by adding desensitizers as well as to the use of BCHPC preparations having a reduced burning rate as an initiator in chemical reactions.

Powder formulation comprising 20-75 wt % of di(4-tert-butylcyclohexyl) peroxydicarbonate and 25-80 wt % of ethylene glycol dibenzoate.

Powder formulation comprising 20-75 wt % of di(4-tert-butylcyclohexyl) peroxydicarbonate and 25-80 wt % of ethylene glycol dibenzoate.